xCures Company Research Report
Company Overview
- Name: xCures, Inc.
- Mission: To transform the value of US healthcare data by delivering data clarity to empower clinical decision-making and continuous improvement of healthcare.
- Founded: 2018
- Founders: No information is available
- Key People:
- Mika Newton: Chief Executive Officer
- Glenn Kramer, PhD: Chief Technology Officer
- Mark Shapiro, MBA, MA: Chief Operating Officer
- Kenny Wong, MS CGC: Chief Product Officer
- Headquarters: 1901 Harrison Street, Suite 1100, Oakland, CA 94612
- Number of Employees: No information is available
- Revenue: No information is available
- Known For: Leveraging state-of-the-art AI to process all types of medical records, turning data chaos into clinical clarity.
Products
Overview
xCures offers a platform that consolidates and normalizes various types of medical records into a comprehensive, searchable dataset, providing healthcare organizations with real-time, actionable insights from complex medical histories. The platform is now available as Software as a Service (SaaS) for healthcare organizations.
Key Products
1. AI-generated Checklists
- Description: Configurable checklists generated through AI, designed to streamline clinical workflows.
- Key Features:
- Customizable for specific medical scenarios.
- Links back to source data for traceable insights.
2. Patient Summaries
- Description: AI-generated summaries providing an overview of a patient’s clinical data.
- Key Features:
- Real-time data synthesis.
- Full traceability to original medical records.
3. Document Search
- Description: Powerful tools to search medical records regardless of format.
- Key Features:
- Semantic search capabilities.
- Supports diverse medical data formats including CDs, PDFs, Faxes, and more.
4. Golden Records
- Description: Comprehensive patient records synthesized for complete clinical insights.
- Key Features:
- Integration with any care workflow.
- Utilizes validated models for reliable data processing.
5. AI Assistant
- Description: Assists with data processing and clinical decision-making.
- Key Features:
- Offers real-time support for clinical decisions.
- Implements robust QC measures to ensure data integrity.
Recent Developments
New Product Launches and Features
- Next-Generation AI-Powered Data Platform: Unveiled at the HLTH Conference in October 2024, this platform provides real-time insights to make informed clinical decisions more efficiently.
- Expanded AI Health Data Platform: As of January 2024, the platform supports all therapeutic areas and is available as a SaaS. This transformation aims to harness real-time, regulatory-grade data for detailed, longitudinal patient datasets.
New Partnerships
- Clarified Precision Medicine: Partnership announced in June 2024 focusing on improving precision oncology to support oncologists and cancer patients.
- Kidney Cancer Association: In May 2024, xCures entered a strategic partnership to empower patients with greater control over their health data and accelerate treatment discovery.
- Aetion® Partnership: Partnership enhanced in December 2023 includes access to five comprehensive oncology datasets to bolster cancer research.
Other Developments
- QHIN Participant Activation: October 2023 marked xCures’ successful activation as a participant in the Qualified Health Information Network (QHIN).
- AWS Marketplace Offering: In December 2023, xCures began offering clinical data extraction as a service in AWS Marketplace, allowing secure, private data ownership for its clients.
- Patent Awarded: In March 2024, xCures was awarded a patent for AI technology enabling virtual trials, improving clinical decisions through continuous learning from patient experiences.
This report consolidates the latest available data on xCures, providing a snapshot of the company's operations, products, and developments in the healthcare AI field.